4.4 Article

Plasma exosomal microRNAs are non-invasive biomarkers of moyamoya disease: A pilot study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Endothelial miR-196b-5p regulates angiogenesis via the hypoxia/miR-196b-5p/ HMGA2/HIF1a loop

Ruizhe Ren et al.

Summary: Angiogenesis is involved in various physiological and pathological processes. MicroRNAs have been found to play a role in angiogenesis regulation, but the specific role of angiomiRs is not fully understood. This study revealed the negative regulatory role of miR-196b-5p in angiogenesis through the hypoxia/miR-196b-5p/HMGA2/HIF1a loop, suggesting the potential of miR-196b-5p as a target for antiangiogenic therapy.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2023)

Article Clinical Neurology

Moyamoya disease-specific extracellular vesicle-derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing

Shinji Ota et al.

Summary: This study conducted a comprehensive analysis of the changes in expression levels of extracellular vesicle-derived microRNAs (miRNAs) in the intracranial cerebrospinal fluid (CSF) of moyamoya disease patients using next-generation sequencing (NGS) and quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The results showed differential expression of miRNAs in moyamoya disease compared to controls, and gene ontology analysis revealed the most significant GO term to be cytoplasmic stress granule.

ACTA NEUROCHIRURGICA (2023)

Article Biotechnology & Applied Microbiology

MicroRNA-489-3p aggravates neuronal apoptosis and oxidative stress after cerebral ischemia-reperfusion injury

LiGuo Song et al.

Summary: This study found that elevated miR-489-3p aggravates neuronal apoptosis and oxidative stress induced by cerebral ischemia-reperfusion injury (CIRI) through targeting SIRT1. Down-regulating miR-489-3p or up-regulating SIRT1 can ameliorate the neural functional damage caused by CIRI.

BIOENGINEERED (2022)

Article Medicine, Research & Experimental

lncRNA-SNHG7-003 inhibits the proliferation, migration and invasion of vascular smooth muscle cells by targeting the miR-1306-5p/SIRT7 signaling pathway

Jianghua Zheng et al.

Summary: This study revealed that SNHG7-003 may inhibit the proliferation, migration and invasion of VSMCs through the miR-1306-5p/SIRT7 signaling pathway, providing a novel basis for the development of treatment strategies for AS.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Article Clinical Neurology

Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study

Yixin Sun et al.

Summary: This study estimated the incidence and prevalence of Moyamoya disease in China using data from national databases, revealing that MMD is relatively common among East Asians, with lower rates in China compared to other East Asian countries. Unique epidemiological features, including a weaker female predominance and a shift in the highest peak of incidence from children to adults, were observed, providing new insights into MMD. Further research is needed to explore the potential pathogenesis of MMD.

STROKE AND VASCULAR NEUROLOGY (2021)

Article Neurosciences

Linking cortical astrocytic neogenin deficiency to the development of Moyamoya disease?like vasculopathy

Xiao Ren et al.

Summary: The study identified cortical astrocytic neogenin (NEO1) deficiency as a risk factor for the development of Moyamoya-like vasculopathy, leading to abnormal proliferation of small blood vessels, vascular dysfunction, and altered gene expression. This finding provides important insights into investigating the mechanisms of Moyamoya-like vasculopathy.

NEUROBIOLOGY OF DISEASE (2021)

Review Clinical Neurology

The mechanobiological theory: a unifying hypothesis on the pathogenesis of moyamoya disease based on a systematic review

Bhanu Jayanand Sudhir et al.

Summary: The study identifies a unifying theory for the pathogenesis of MMA, suggesting that it is a result of mechanobiological processes. Systematic reviews following PRISMA guidelines reveal common patterns in the development of MMA, shedding light on MMD and MMS.

NEUROSURGICAL FOCUS (2021)

Article Clinical Neurology

Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells

Xia Wang et al.

Summary: This study identified dysregulated cell growth and maintenance, immune dysfunction in hemorrhagic MMD, and promoted proliferation in neuroblastoma cells through proteomic analysis of SDEs in MMD patients. Treatment with MMD SDEs increased proliferation in mouse brain vascular EC cells and induced dysfunction of mitochondria in cerebrovascular ECs from hemorrhagic MMD patients, providing potential therapeutic strategies for MMD.

STROKE (2021)

Article Medicine, Research & Experimental

MicroRNA-145-5p inhibits hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes by targeting ROCK1

Chao Cheng et al.

Summary: This study reveals that overexpression of miR-145-5p inhibits H/R-induced cardiomyocyte apoptosis by targeting ROCK1.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Review Clinical Neurology

Neurologic Complications of Sickle Cell Disease

Shama Farooq et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)

Review Clinical Neurology

Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease

Takeshi Mikami et al.

NEUROLOGIA MEDICO-CHIRURGICA (2019)

Article Clinical Neurology

Low serum miR-320b expression as a novel indicator of carotid atherosclerosis

Rong Zhang et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2016)

Article Genetics & Heredity

Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects

Christina Backes et al.

MOLECULAR DIAGNOSIS & THERAPY (2016)

Review Pharmacology & Pharmacy

Understanding the Activity of Antibiotics in Cerebrospinal Fluid in vitro

Peter Matzneller et al.

PHARMACOLOGY (2016)

Review Genetics & Heredity

Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function

Jian Zhang et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2015)

Article Multidisciplinary Sciences

Serum miRNA Signature in Moyamoya Disease

Dongwei Dai et al.

PLOS ONE (2014)

Article Clinical Neurology

Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass

Robert M. Starke et al.

NEUROSURGICAL FOCUS (2009)

Review Medicine, General & Internal

MEDICAL PROGRESS Moyamoya Disease and Moyamoya Syndrome

R. Michael Scott et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)